Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Velcade

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Velcade was produced by Johnson & Johnson and Takeda.

FDA clears first-line use for J&J’s myeloma drug Darzalex

FDA clears first-line use for J&J’s myeloma drug Darzalex

The company’s Janssen unit says Darzalex (daratumumab) has been given the nod for use alongside Takeda’s Velcade (bortezomib), melphalan and prednisone (VMP) for newly-diagnosed myeloma patients who are

Darzalex powers ahead with frontline myeloma approval in Europe

Darzalex powers ahead with frontline myeloma approval in Europe Its pharma division Janssen has gained EU approval for its use alongside Takeda’s Velcade (bortezomib), melphalan and prednisone (VMP) for newly-diagnosed myeloma patients who are ineligible for high-dose

Immunology keeps Shire figures solid as Takeda takeover nears

Immunology keeps Shire figures solid as Takeda takeover nears In its latest quarter, net profit almost halved on flat sales, with its big-selling cancer drug Velcade (bortezomib) down 11% after losing patent protection in the US last year.

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market Under her leadership the US pharma company produced blockbuster-selling drugs like Velcade before it was sold to Takeda back in 2008.

Safety scuppers combo trials with J&J/Genmab’s Darzalex

Safety scuppers combo trials with J&J/Genmab’s Darzalex The company and J&J are working to advance Darzalex into front-line myeloma therapy, picking up approval in the US for use alongside Takeda’s Velcade (bortezomib), melphalan and prednisone

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics